Kolexia
Denizon Nathalie Hématologie
Denizon Nathalie
Hématologie
Centre Hospitalier du Mans
Le Mans, France
58 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphome B Lymphomes Myélome multiple Tumeurs hématologiques Syndromes myélodysplasiques Leucémies Hémorragie Lymphome B de la zone marginale Leucémie aigüe myéloïde

Collaborateurs

Voir plus
Ghnaya Habib
Ghnaya Habib
Centre Hospitalier du Mans, Le Mans, France
Bergelin-Besancon Anne
Bergelin-Besancon Anne
Centre Hospitalier du Mans, Le Mans, France
Laribi Kamel
Laribi Kamel
Centre Hospitalier du Mans, Le Mans, France
Farhi Jonathan
Farhi Jonathan
Hôpital Larrey Angers, Angers, France

Industries

Voir plus
B3TSI
114 collaboration(s)
Dernière en 2023
P\S\L Group Services
40 collaboration(s)
Dernière en 2023
A+A
36 collaboration(s)
Dernière en 2023
All Global
27 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
Impact of the relative dose intensity on survival of patients with high-risk myelodysplastic syndromes treated with Azacitidine.
Cancer medicine   16 avril 2019
Chronic lymphocytic leukemia with t(14 ;18) and trisomy 12: a case report.
Annales de biologie clinique   05 novembre 2018
Lymphoplasmacytic lymphoma or multiple myeloma: immunoglobulins may lead to misdiagnosis.
Annales de biologie clinique   05 novembre 2018
Prognostic impact of elevated pretreatment serum ferritin in patients with high-risk MDS treated with azacitidine.
Experimental hematology   05 juin 2018
Significant impact of immunosuppression on the incidence of secondary malignancies following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with indolent B-cell neoplasms.
Leukemia & lymphoma   21 mars 2018
Inguinal lymphadenopathy of cat-scratch disease mimicking malignant hemopathy on 18FDG-PET/CT
Médecine Nucléaire   01 novembre 2017
R-CVP regimen is active in frail elderly patients aged 80 or over with diffuse large B cell lymphoma.
Annals of hematology   03 août 2016
The bendamustine plus rituximab regimen is active against primary nodal marginal zone B-cell lymphoma.
Hematological oncology   22 juillet 2016
Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation   26 mars 2016
Rituximab is an effective and safe treatment of relapse in elderly patients with resistant warm AIHA.
Annals of hematology   09 février 2016